| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-93 |
Sentence |
denotes |
Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: |
| T1 |
0-93 |
Sentence |
denotes |
Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: |
| TextSentencer_T2 |
94-147 |
Sentence |
denotes |
GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. |
| T2 |
94-147 |
Sentence |
denotes |
GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. |
| TextSentencer_T3 |
148-349 |
Sentence |
denotes |
Sialyl-Tn antigen (STn) is a cancer associated carbohydrate antigen over-expressed in several cancers including breast cancer, and currently associated with more aggressive diseases and poor prognosis. |
| T3 |
148-349 |
Sentence |
denotes |
Sialyl-Tn antigen (STn) is a cancer associated carbohydrate antigen over-expressed in several cancers including breast cancer, and currently associated with more aggressive diseases and poor prognosis. |
| TextSentencer_T4 |
350-458 |
Sentence |
denotes |
However, the commonly used breast cancer cell lines (MDA-MB-231, T47-D and MCF7) do not express STn antigen. |
| T4 |
350-458 |
Sentence |
denotes |
However, the commonly used breast cancer cell lines (MDA-MB-231, T47-D and MCF7) do not express STn antigen. |
| TextSentencer_T5 |
459-586 |
Sentence |
denotes |
The key step in the biosynthesis of STn is the transfer of a sialic acid residue in alpha2,6-linkage to GalNAc alpha-O-Ser/Thr. |
| T5 |
459-586 |
Sentence |
denotes |
The key step in the biosynthesis of STn is the transfer of a sialic acid residue in alpha2,6-linkage to GalNAc alpha-O-Ser/Thr. |
| TextSentencer_T6 |
587-684 |
Sentence |
denotes |
This reaction is mainly catalyzed by a CMP-Neu5Ac GalNAc alpha2,6-sialyltransferase: ST6GalNAc I. |
| T6 |
587-684 |
Sentence |
denotes |
This reaction is mainly catalyzed by a CMP-Neu5Ac GalNAc alpha2,6-sialyltransferase: ST6GalNAc I. |
| TextSentencer_T7 |
685-826 |
Sentence |
denotes |
In order to generate STn-positive breast cancer cells, we have cloned a cDNA encoding the full-length human ST6GalNAc I from HT-29-MTX cells. |
| T7 |
685-826 |
Sentence |
denotes |
In order to generate STn-positive breast cancer cells, we have cloned a cDNA encoding the full-length human ST6GalNAc I from HT-29-MTX cells. |
| TextSentencer_T8 |
827-970 |
Sentence |
denotes |
The stable transfection of MDA-MB-231 with an expression vector encoding ST6GalNAc I induces the expression of STn antigen at the cell surface. |
| T8 |
827-970 |
Sentence |
denotes |
The stable transfection of MDA-MB-231 with an expression vector encoding ST6GalNAc I induces the expression of STn antigen at the cell surface. |
| TextSentencer_T9 |
971-1184 |
Sentence |
denotes |
The expression of STn short cuts the initial O-glycosylation pattern of these cell lines, by competing with the Core-1 beta1,3-galactosyltransferase, the first enzyme involved in the elongation of O-glycan chains. |
| T9 |
971-1184 |
Sentence |
denotes |
The expression of STn short cuts the initial O-glycosylation pattern of these cell lines, by competing with the Core-1 beta1,3-galactosyltransferase, the first enzyme involved in the elongation of O-glycan chains. |
| TextSentencer_T10 |
1185-1326 |
Sentence |
denotes |
Moreover, we show that STn expression is associated with morphological changes, decreased growth and increased migration of MDA-MB-231 cells. |
| T10 |
1185-1326 |
Sentence |
denotes |
Moreover, we show that STn expression is associated with morphological changes, decreased growth and increased migration of MDA-MB-231 cells. |